Better Nutrition, Better Brain

By Janet Gulland, Contributing Writer

A spate of recent studies provides strong support for the notion that diet and lifestyle inteventions alone can mitigate or even prevent Alzheimer’s disease and other forms of age-related demetia. Researchers are uncovering the mechanisms underlying the neuroprotective effects. (Image: YARUNIV Studio/Shutterstock)

If we have any chance of mitigating the rising tide of Alzheimer’s and other forms of dementia, it’s going to be via diet and lifestyle interventions, not expensive but minimally effective prescription drugs.

Fortunately, there is a swell of new data to support the notion that nutrition-based interventions can slow the progression of dementia, and may even be able to prevent it. The idea that holistic approaches can avert cognitive decline is no longer speculative. Increasingly, it is evidence-based.

Case in point, the June 2024 randomized, controlled study published by a multicenter team led by Dean Ornish, MD, founder of the Preventive Medicine Research Institute. The study involved 51 patients with mild cognitive impairment or early-stage Alzheimer’s (AD), randomized to usual care with no lifestyle changes (N=25), or a 20-week intensive diet and lifestyle intervention centered on a whole food vegan diet, with daily exercise, stress reduction, social activity, and a sizeable stack of nutraceuticals.

[ ...Read More ]

NSCC Conference Preview: The Science & Practice of Healthy Aging

Written by Robert Bonakdar, MD

There are numerous claims about what supports longevity and healthspan, and it can be difficult to discern what is real from what is hype in this overheated field. That is why we’ve made The Science and Practice of Healthy Aging the theme of the 2nd annual Nutrition & Supplementation in Clinical Care (NSCC) Conference, which […]

[ ...Read More ]

Noise: Not Just a Nuisance, It’s a Public Health Risk

Written by Erik Goldman

Back at the turn of the 20th Century, physician-bacteriologist Robert Koch predicted that, “One day, man will have to fight noise as fiercely as cholera and the plague.” That day is definitely upon us. The detrimental impact of noise goes far beyond the obvious problem of hearing loss. Over the last decades, researchers have shown, […]

[ ...Read More ]

The Metabolic Vulnerability Index: A Breakthrough for Predicting Chronic Disease

Written by Erik Goldman

View Webinar

The Metabolic Vulnerability Index (MVX) is a revolutionary new algorithmic test that quantifies six key biomarkers — small HDL particles, GlycA, branched-chain amino acids (valine, leucine, isoleucine) and citrate—each highly predictive of poor cardiometabolic outcomes.

Combined into a single Index score from 1 to 100, the MVX identifies drivers of poor health often years before symptoms appear. The MVX Plus provides insight into toxin exposures, latent infections, systemic inflammation, and mitochondrial dysfunction. Also available are sub-indexes for Inflammation Vulnerability and Metabolic Malnutrition.

Innovative, inexpensive, and now widely accessible, the MVX empowers you to measure, guide, and track your patients’ health with scientific precision.

Join Dr. Darren Schmidt—the nation’s foremost experts on the clinical application of MVX—for an in-depth look at what this test detects, how to implement it in real-world practice, and most importantly, how it can strengthen your clinical acumen and improve your patients’ lives!

View Webinar

SPONSORED BY: Professional Co-op Services